Different immune infiltrating cells are complex and changeable in the occurrence and development of tumors, so for different tumors, the study of the relationship between RMI2 and immune infiltration-related cells can promote tumor immunity and drug development and therapy. The gene discussed is RMI2; the disease is neoplasm.